Clinical Trial Update: A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy [Phase 3]

View source ↗

Summary

Phase 3 study evaluating seltorexant as an adjunctive therapy to antidepressants in adults and elderly patients with major depressive disorder and insomnia; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia
• Major Depressive Disorder

Drugs mentioned

• Seltorexant (seltorexant)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Depressive Disorder, Major | Phase 3 | Status: TERMINATED | Results posted: 2025-06-04